[1] 国家心血管病中心. 中国心血管健康与疾病报告2019[J]. 心肺血管病杂志, 2020, 39(10):1157-1162. [2] FONG I W. Emerging relations between infectious diseases and coronary artery disease and atherosclerosis[J]. CMAJ, 2000, 163(1): 49-56. [3] ROSS R. Mechanisms of atherosclerosis-a review[J]. Adv Nephrol Necker Hosp, 1990, 19:79-86. [4] TABAS I, LICHTMAN A H. Monocyte-macrophages and T cells in atherosclerosis[J]. Immunity, 2017, 47(4):621-634. [5] HANSSON G K. Inflammation, atherosclerosis, and coronary artery disease[J]. N Engl J Med, 2005, 352(16):1685-1695. [6] 王静, 廖荣宏. 瘦素在冠心病发病机制中的最新进展[J]. 现代医药卫生, 2014, 30(10):1494-1496. [7] MÜNZBERG H, MORRISON C D. Structure, production and signaling of leptin[J]. Metabolism, 2015, 64(1):13-23. [8] ZHANG F M, CHEN Y Y, Heiman M, et al. Leptin: structure, function and biology[J]. Vitam Horm, 2005, 71:345-372. [9] LIU J R, YANG X N, YU S W, et al. The leptin resistance[J]. Adv Exp Med Biol, 2018, 1090:145-163. [10] CRUJEIRAS A B, CARREIRA M C, CABIA B, et al. Leptin resistance in obesity: an epigenetic landscape[J]. Life Sci, 2015, 140:57-63. [11] 陈晓燕, 常志文. 老年原发性高血压患者血清瘦素和可溶性瘦素受体水平与血糖、血脂的相关性[J]. 中国临床康复, 2005, 9(7):40-42. [12] XIA N, LI H G. The role of perivascular adipose tissue in obesity-induced vascular dysfunction[J]. Br J Pharmacol, 2017, 174(20):3425-3442. [13] SARKAR N C, SARKAR P, SARKAR P, et al. Association of coronary heart disease and CRP-as a noble marker of inflammation-A Case Control Study[J]. J Assoc Physicians India, 2019,67(10):54-56. [14] HRIBAL M L, FIORENTINO T V, SESTI G. Role of C reactive protein (CRP) in leptin resistance[J]. Curr Pharm Des, 2014, 20(4):609-615. [15] TAKAHASHI Y, SATOH M, TABUCHI T,et al. Prospective, randomized, single-blind comparison of effects of 6 months’ treatment with atorvastatin versus pravastatin on leptin and angiogenic factors in patients with coronary artery disease[J]. Heart Vessels, 2012, 27(4):337-343. [16] 赵勇, 王洪杰, 曾和松. 瘦素基因启动子G-2548A多态性与冠心病的关系[J]. 临床内科杂志, 2006, 23(7):489-491. [17] 郑权秀, 刘庆利, 倪崇庆, 等. 瘦素基因启动子C2549A多态性位点基因与早发冠心病的相关性分析[J]. 实用医学杂志, 2014, 30(17):2789-2791. [18] WANG H D, WANG C, HAN W X, et al. Association of leptin and leptin receptor polymorphisms with coronary artery disease in a North Chinese Han population[J]. Rev Soc Bras Med Trop, 2020, 53:e20190388. [19] 谭艺青, 赵小蕾, 陈业达, 等. 瘦素及瘦素受体基因多态性与中国南方汉族人群冠心病的关联研究[J]. 现代预防医学, 2016, 43(4):601-606. [20] 陈元, 楚天舒, 武力勇. 瘦素抵抗、瘦素受体基因多态性与冠状动脉粥样硬化性心脏病的相关性进展[J]. 心血管病学进展, 2019, 40(8):1130-1133. [21] WOLK R, BERGER P, LENNON R J, et al. Plasma leptin and prognosis in patients with established coronary atherosclerosis[J]. J Am Coll Cardiol, 2004, 44(9):1819-1824. |